Two hospital groups are arguing that federal staffing mandates are a “one-size-fits-all” approach to the labor crisis and that issuing mandates could reduce capacity by forcing nursing homes to shut their doors.
Provider groups push back on planned nursing home staff mandates Read More »
The state attorney general’s office has cautioned against a quick merger since the deal was first announced in November.
Sanford, Fairview delay merger indefinitely; Minnesota AG continues review of deal Read More »
Almost 99% of hospital websites include tracking software that transfer data to third parties, including technology and social media companies, data brokers, advertisers and even private equity firms, a new study found.
While financier Carl Icahn and regulators in the U.S. and Europe want DNA-sequencing company Illumina to divest liquid biopsy company Grail, Illumina’s board won’t budge. Analysts say they may be waiting for the best moment.
With an inaugural $350 million fund, Cure Ventures launched Tuesday to support early-stage companies with cutting-edge curative technologies and help them de-risk their science
Cure Ventures Launches with $350M to De-Risk Innovation Read More »
Gossamer Bio announced Monday that it is discontinuing the development of its lymphoma candidate, GB5121, following two patient deaths in the Phase Ib/II STAR-CNS study.
Gossamer Cuts Lymphoma Drug After Two Fatalities Read More »
The FDA has approved the combination regimen of Merck’s Keytruda and Seagen and Astellas’ Padcev for the first-line treatment of locally advanced or metastatic urothelial carcinoma.
FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer Read More »
Se ha puesto en marcha un ensayo clínico para poner a prueba la eficacia de un nuevo tratamiento orientado a reducir el impacto de las infecciones en los pacientes trasplantados de corazón. El ensayo es de alcance nacional (en toda España) y lo lideran desde el Hospital …
Mitigar el riesgo de infección en los pacientes trasplantados de corazón Read More »
Un estudio exhaustivo ha determinado recientemente hasta qué punto los niños y niñas con trastorno del espectro autista están en riesgo de sufrir problemas emocionales. El estudio lo ha realizado el grupo de investigación Nutrición y Salud Mental de …
With data from the Phase III trial of donanemab expected in Q2, Eli Lilly presented the first clinical results from its next anti-amyloid antibody, remternetug, at AD/PD 2023.
Lilly Debuts Next Alzheimer’s Drug, Will Test Subcutaneous Potential Read More »
